Qingyu Xiu

6.7k total citations
61 papers, 1.4k citations indexed

About

Qingyu Xiu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Qingyu Xiu has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 18 papers in Physiology and 13 papers in Immunology. Recurrent topics in Qingyu Xiu's work include Asthma and respiratory diseases (16 papers), Lung Cancer Treatments and Mutations (9 papers) and IL-33, ST2, and ILC Pathways (8 papers). Qingyu Xiu is often cited by papers focused on Asthma and respiratory diseases (16 papers), Lung Cancer Treatments and Mutations (9 papers) and IL-33, ST2, and ILC Pathways (8 papers). Qingyu Xiu collaborates with scholars based in China, Japan and United States. Qingyu Xiu's co-authors include Wei Nie, Bing Li, Jiquan Chen, Hao Tang, Yi Zhang, Hai Huang, Fang Zheng, Keum Ji Jung, Sun Ha Jee and Bing Li and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Qingyu Xiu

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyu Xiu China 22 440 393 372 327 289 61 1.4k
Morio Nakamura Japan 18 780 1.8× 327 0.8× 234 0.6× 237 0.7× 174 0.6× 62 1.4k
M. Kristen Demoruelle United States 29 791 1.8× 556 1.4× 414 1.1× 488 1.5× 168 0.6× 67 3.1k
Seung Soo Yoo South Korea 22 640 1.5× 583 1.5× 286 0.8× 125 0.4× 356 1.2× 150 1.7k
Seung Ick South Korea 25 976 2.2× 626 1.6× 440 1.2× 183 0.6× 374 1.3× 181 2.2k
Namık Yaşar Özbek Türkiye 21 269 0.6× 186 0.5× 313 0.8× 151 0.5× 140 0.5× 206 1.7k
Young-Soo Shim South Korea 22 559 1.3× 382 1.0× 358 1.0× 126 0.4× 192 0.7× 54 1.6k
Hee Seok Moon South Korea 20 477 1.1× 201 0.5× 187 0.5× 151 0.5× 268 0.9× 155 1.4k
Vı́tězslav Kolek Czechia 21 746 1.7× 376 1.0× 167 0.4× 356 1.1× 413 1.4× 87 1.4k
Yosef S. Haviv Israel 22 239 0.5× 520 1.3× 160 0.4× 139 0.4× 459 1.6× 87 1.6k
Lewis Wesselius United States 23 579 1.3× 223 0.6× 156 0.4× 158 0.5× 99 0.3× 59 1.3k

Countries citing papers authored by Qingyu Xiu

Since Specialization
Citations

This map shows the geographic impact of Qingyu Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Xiu more than expected).

Fields of papers citing papers by Qingyu Xiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Xiu. The network helps show where Qingyu Xiu may publish in the future.

Co-authorship network of co-authors of Qingyu Xiu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Xiu. A scholar is included among the top collaborators of Qingyu Xiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Xiu. Qingyu Xiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yongan, et al.. (2016). B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.. PubMed. 13(2). 89–99. 22 indexed citations
2.
Fan, Xiaohong & Qingyu Xiu. (2015). Effect of X-ray repair cross complementing group 1 polymorphisms on the efficacy of platinum-based chemotherapy in patients with nonsmall cell lung cancer. Journal of Cancer Research and Therapeutics. 11(3). 571–574. 4 indexed citations
3.
Nie, Wei, Bing Li, & Qingyu Xiu. (2014). β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 69(6). 1441–1446. 67 indexed citations
4.
Nie, Wei, et al.. (2014). TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls. Tumor Biology. 35(6). 5569–5574. 10 indexed citations
5.
Xiao, Dan, Nanshan Zhong, Chunxue Bai, et al.. (2014). Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians. Frontiers of Medicine. 8(1). 84–90. 5 indexed citations
6.
Chen, Jiquan, Yuan‐Sheng Zang, & Qingyu Xiu. (2014). BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis. Tumor Biology. 35(10). 9855–9858. 6 indexed citations
7.
Nie, Wei, Cheng Xue, Jiquan Chen, & Qingyu Xiu. (2013). Secretoglobin 1A member 1 (SCGB1A1) +38A/G polymorphism is associated with asthma risk: A meta-analysis. Gene. 528(2). 304–308. 14 indexed citations
9.
Nie, Wei, Yuan‐Sheng Zang, Jiquan Chen, & Qingyu Xiu. (2013). Association between Interleukin-4 Receptor α Chain (IL4RA) I50V and Q551R Polymorphisms and Asthma Risk: An Update Meta-Analysis. PLoS ONE. 8(7). e69120–e69120. 17 indexed citations
11.
Nie, Wei, Hao Tang, Zheng Fang, et al.. (2012). Hydrogenase: the next antibiotic target?. Clinical Science. 122(12). 575–580. 11 indexed citations
12.
Zhao, Liming, Lei Jiang, Jin He, et al.. (2012). UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 138(11). 1951–1961. 15 indexed citations
13.
Nie, Wei, Zheng Fang, Bing Li, & Qingyu Xiu. (2012). Interleukin-10 promoter polymorphisms and asthma risk: A meta-analysis. Cytokine. 60(3). 849–855. 37 indexed citations
14.
Tang, Hao, et al.. (2010). YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. European Respiratory Journal. 35(4). 757–760. 84 indexed citations
15.
Wang, Jin, Yonghong Xiao, Wenxiang Huang, et al.. (2010). A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections. Chemotherapy. 56(5). 378–385. 14 indexed citations
16.
Tang, Hao, et al.. (2010). Isolated splenic metastasis from lung cancer: ringleader of continuous fever. European Respiratory Review. 19(117). 253–256. 19 indexed citations
17.
Chen, Jiquan, Hao Tang, Bing Li, & Qingyu Xiu. (2010). Rosai–Dorfman disease of multiple organs, including the epicardium: An unusual case with poor prognosis. Heart & Lung. 40(2). 168–171. 29 indexed citations
18.
Tang, Hao, et al.. (2007). Cyclooxygenase-2 induction requires activation of nuclear factor of activated T-cells in Beas-2B cells after vanadium exposure and plays an anti-apoptotic role. Archives of Biochemistry and Biophysics. 468(1). 92–99. 17 indexed citations
19.
Luo, Weiren, et al.. (1999). Effects of BRL 55 834 on allergen-induced bronchoconstriction and airway inflammation in sensitized guinea pigs.. PubMed. 112(11). 988–91. 1 indexed citations
20.
Fujimura, M, et al.. (1994). Involvement of Thromboxane A2 in Propranolol-Induced Bronchoconstriction After Allergic Bronchoconstriction in Guinea Pigs. American Journal of Respiratory and Critical Care Medicine. 149(6). 1488–1493. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026